Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)

Andrei-Nicolae Vasilescu,1,* Nina Schweinfurth,2,* Stefan Borgwardt,2,* Peter Gass,1 Undine E Lang,2,* Dragos Inta,1,2,* Sarah Eckart2,* 1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; 2Department...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vasilescu AN, Schweinfurth N, Borgwardt S, Gass P, Lang UE, Inta D, Eckart S
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
Accès en ligne:https://doaj.org/article/1a720397f9c44e768d8c24e2c20a934c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!